Josefina Udi

I am a medical doctor graduated from the University of Buenos Aires, specialist in internal medicine and critical care medicine, with a Ph.D. in medicine from the University of Freiburg in Germany.

After finishing my medical education at the University of Buenos Aires in Argentina, I worked as a researcher at the University of Freiburg, where I completed my PhD in multiple myeloma. Afterwards, I continued working as a PostDoc and published several peer-reviewed articles in translational and clinical research in the field of hematology and oncology. During this period, I have authored and co-authored several conference abstracts and presentations.

I completed my clinical training, in internal medicine first and later on in critical care medicine, at the University Hospital in Freiburg. During my clinical training I continued working on clinical research, changing my research focus to topics mostly related to critical care and cardiology.

With 16 years of experience in patient care, I have worked during the last 10 years as an attending physician at the Department of Interdisciplinary Medical Intensive Therapy of the University Hospital in Freiburg until July 2026, when I decided to return and continue working in Argentina.

I am fluent in English, German and Spanish.

Growing up, living and working in a multicultural environment might have not only contributed to further develop my language knowledges, but also to shape my empathy, adaptability, communication skills and critical thinking.

Microsoft Office proficiency (Word, Excel, PowerPoint, Outlook)

• Principal Investigator Training Course (2010)
• Scientific Writing Workshop (2011)
• Advanced Life Support (ALS) Provider Course (2020)
• Bronchoscopy Course (2017)

• Molecular Oncology Module, “International Master Program in Biomedical Sciences” (IMBS), Freiburg, Germany (2011-2014)
• Immunology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Argentina (2013-2014)
• University Freiburg Nursing School, Intermediate and Intensive Care Specialization, Freiburg, Germany (2022-current)
• Internal Medicine, University Medical Center Freiburg, Freiburg, Germany (2022-current)

Peer-reviewed articles:

• Udi J, Sekandarzad A, Supady A, Biever P, Bode C, Zehender M, Busch HJ, Wengenmayer T, Staudacher DL, Duerschmied D. Coronary angiography following out-of-hospital cardiac arrest (OHCA): a review of outcomes and clinical considerations. Expert Review of Cardiovascular Therapy 2021; 19 (12):1045-1051.
• Udi J, Lang CN, Zotzmann V, Krueger K, Fluegler A, Bamberg F, Bode C, Dürschmied D, Wengenmayer T, Staudacher DL. Incidence of Barotrauma in Patients With COVID-19 Pneumonia During Prolonged Invasive Mechanical Ventilation - A Case-Control Study. Journal of Intensive Care Medicine 2021; 36 (4):477-483.
• Udi J, Köhler T, Grohmann J, Bäuml M, Grundmann S, Bode C, Biever P, Dürschmied D. A Challenging case of severe pulmonary bleeding in a patient with congenital ventricular septal defekt (VSD) and Eisenmenger syndrome: extracorporeal membrane oxygenation (ECMO) support and weaning trategies. Clinical Research in Cardiology 2019; 109 (3): 403-407.
• Bäuml M, Udi J, Klingel K, Bode C, Warnatz K, Zirlik A, Duerschmied D, Biever P. Severe eosinophilic myocarditis associated with modafinil in a patient with normal peripher eosinophilic count. Clinical Research in Cardiology 2019; 108 (8): 963-966.
• Sekandarzad A, Udi J, Waller CF, Bode C, Biever P. Extracorporeal Membrane Oxygenation Support as a Bridge to Recovery during Chemotherapy in a Young Patient with Metastatic Choriocarcinoma and Severe Acute Respiratory Distress Syndrome. Oncology Research and Treatment 2020; 43 (10): 559-564.
• Udi J, Schüler J, Wider D, Ihorst G, Catusse J, Waldschmidt J, Schnerch D, Follo M, Wäsch R, Engelhardt M. Potent in vitro and in vivo activity of sorafenib in multiple myeloma: induction of cell death, CD138-downregulation and inhibition of migration through actin depolymerization. British Journal of Haematology. 2013 Apr; 161 (1): 104-16.
• Udi J, Wider D, Kleber M, Ihorst G, Müller A, Wäsch R, Engelhardt M. Early and mature endothelial progenitors and VEGFR2+-cells in multiple myeloma: association with disease characteristics and variation in different cell compartments. Leukemia Research 2011; 35 (9): 1265-8.
• Can E, Doppler MC, Wintergerst C, Efinger N, Udi J, Sekandarzad A, Uller W, Vogt K, Grundmann S. Resolving a sticky situation: A case report of mechanical thrombectomy of Histoacryl emboli in the right atrium and inferior vena cava. Radiology Case Reports 2024; 19 (11):5313-5317.
• Schnerch D, Schmidts A, Follo M, Udi J, Felthaus J, Pfeifer D, Engelhardt M, Wäsch R. BubR1 is frequently repressed in acute myeloblastic leukemia and its re-expression sensitizes to antimitotic therapy. Haematologica. 2013; 98(12):1886-95.
• Kleber M*, Udi J*, Metzke B, Terpos E, Roodman GD, Morgan G, Dispenzieri A, Einsele H, Wäsch R, Engelhardt M. Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy. Leukemia & Lymphoma 2012 Jun; 53 (6): 1057-61 (*both authors contributed equally).
• Engelhardt M, Udi J, Kleber M, Spencer A, Rocci A, Knop S, Bruno B, Bringhen S, Pérez-Simón J.A, Zweegman S, Driessen C, Patriarca F, Gramatzki M, Terpos E, Sezer O, Kropff M, Straka C, Johnsen H.E, Waage A, Boegsted M, Lokhorst H, Hájek R, Morgan G, Boccadoro M, Ludwig H, Cavo M, Polliack A, Sonneveld P, Einsele H, Palumbo A. Leukemia & Lymphoma 2010 Nov; 51 (11): 2006-11.
• Engelhardt M, Kleber M, Udi J, Wäsch R, Spencer A, Patriarca F, Knop S, Benedetto B, Gramatzki M, Morabito F, Kropff M, Neri A, Sezer O, Hajek R, Bunjes D, Boccadoro M, Straka C, Cavo M, Polliack A, Einsele H, Palumbo A. Consensus statement from European experts on the diagnosis, management and treatment of multiple myeloma: from standard therapy to novel approaches. Leukemia & Lymphoma 2010.
• Kleber M, Ihorst G, Udi J, Koch B, Wäsch R, Engelhardt M. Prognostic risk factor evaluation in patients with relapsed or refractory multiple myeloma and lenalidomide treatment: analysis of renal function via eGFR and of additional comorbidities via comorbidity appraisal. Clin Lymphoma Myeloma Leuk. 2012 Feb; 12 (1): 38-48.
• Sonneveld P, Cavo M, Einsele H, Knop S, Straka C, Boccadoro M, Kropff M, Morabito F, Gramatzki M, Spencer A, Bruno B, Bunjes D, Engelhardt M, Kleber M, Udi J, Patriarca F, Polliack A, Sezer O, Hajek R, Omede P, Neri A, Palumbo A. A new co-operative group: the European Myeloma Network Trialist Group. Leukemia & Lymphoma 2009; 50 (10): 1581-1588.
• Chevalier N, Udi J, Sigler M, Wolf ME, Heinz J, Schmitt-Graeff A, Seufert J, Wäsch R, Engelhardt M. Interplay of Parathyroid hormone-related peptide (PTHrP), renal insufficiency and bulky disease in the pathogenesis of hypercalcemia in Hodgkin´s lymphoma (HL). European Journal of Hematology 2010 Oct; 85 (4): 368-9.
• Engelhardt M, Ihorst G, Udi J, Kleber M, Rawluk J, Wäsch R. Does Colorectal Cancer in Ulcerative Colitis Patients Constitute a Risk for Chemotherapy Refractoriness? A Systemic Approach by Detailed Analysis via the Electronic Tumor Base Documentation System. Onkologie 2011; 34 (12): 688-94.
• Yalcintepe J, Hellige T, Kleber M, Udi J, Wäsch R, Engelhardt M. Knochenbeteiligung beim Multiplen Myelom und anderen Tumorerkrankungen: Von Bisphosphonaten zu zielgerichteten Therapien. Onkologische Welt 2011; 2: 258-262.
• Reinhardt H, Metzke B, Udi J, Kleber M, Engelhardt M. Innovative Substanzen und Behandlungsmethoden beim multiplen Myelom. Krankenhauspharmazie 2012; 33: 467-474.
• Engelhardt M, Kleber M, Udi J, Wäsch R. Current approaches in multiple myeloma and other cancer-related bone diseases-from bisphosphonates through to targeted therapy. Deutsches Medizinisches Wochenschrift 2012; 137: 1057-1061.

Co-authorship of books

2012  „Das Blaue Buch”. Chemotherapie-Manual. Hämatologie und Onkologie.

Springer Verlag, 4. Auflage. Herausgeber: M. Engelhardt, D. Berger, R.     Mertelsmann.

2013  „Das Rote Buch“. Hämatologie und Internistische Onkologie.

Ecomed Verlag, 5. Auflage. Herausgeber: D. P. Berger, J. Duyster, M. Engelhardt, R. Engelhardt, H. Henß und R. Mertelsmann.